Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Non-cash Items (2016 - 2025)

Pharma-Bio Serv's Non-cash Items history spans 13 years, with the latest figure at $4000.0 for Q4 2025.

  • For Q4 2025, Non-cash Items fell 98.76% year-over-year to $4000.0; the TTM value through Oct 2025 reached $4000.0, down 98.76%, while the annual FY2025 figure was $4000.0, 52.18% down from the prior year.
  • Non-cash Items reached $4000.0 in Q4 2025 per PBSV's latest filing, down from $323370.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $400000.0 in Q4 2022 to a low of $4000.0 in Q4 2025.
  • Average Non-cash Items over 5 years is $277480.0, with a median of $323370.0 recorded in 2024.
  • Peak YoY movement for Non-cash Items: skyrocketed 95.71% in 2021, then plummeted 98.76% in 2025.
  • A 5-year view of Non-cash Items shows it stood at $396700.0 in 2021, then grew by 0.83% to $400000.0 in 2022, then crashed by 34.17% to $263330.0 in 2023, then grew by 22.8% to $323370.0 in 2024, then tumbled by 98.76% to $4000.0 in 2025.
  • Per Business Quant, the three most recent readings for PBSV's Non-cash Items are $4000.0 (Q4 2025), $323370.0 (Q4 2024), and $263330.0 (Q4 2023).